# CORRESP — Kalaris Therapeutics, Inc. (KLRS) (CIK 0001754068) > Kalaris Therapeutics, Inc. (KLRS) (CIK 0001754068) → SEC staff · filed 2026-04-09 · ticker KLRS · SIC 2836 ## What is this A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters. ## Key facts - **Accession number:** 0001193125-26-149596 - **Form:** CORRESP - **Filer:** Kalaris Therapeutics, Inc. (KLRS) (CIK 0001754068) - **CIK:** 0001754068 - **Ticker:** KLRS - **Filed:** 2026-04-09 - **SIC industry:** 2836 - **HQ:** Berkeley Heights, NJ ## Primary source PDF letter: https://www.sec.gov/Archives/edgar/data/1754068/000119312526149596/filename1.htm EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1754068&type=UPLOAD&dateb=&owner=include&count=40 ## Other comment-letter activity for Kalaris Therapeutics, Inc. (KLRS) (CIK 0001754068) - CORRESP — 2026-04-09 — /comment-letter/0001193125-26-149595 - UPLOAD — 2026-04-08 — /comment-letter/0000000000-26-003516 - UPLOAD — 2026-04-08 — /comment-letter/0000000000-26-003517 ## Citation > US Securities and Exchange Commission, EDGAR CORRESP comment letter, Kalaris Therapeutics, Inc. (KLRS) (CIK 0001754068) (CIK 0001754068), filed 2026-04-09, accession 0001193125-26-149596. Retrieved via MORVS 2026-11-03 from https://api.morvs.ai/comment-letter/0001193125-26-149596. --- *[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*